LATEST NEWS: FDA approves Radius Health's osteoporosis drug Tymlos - (Reuters) - The U.S. Food and Drug Administration on Friday approved Radius Health Inc's drug to treat osteoporosis in postmenopausal women at high risk of fracture or those who have failed other therapies.
LATEST NEWS: Mexican Congress approves use of medical marijuana - MEXICO CITY (Reuters) - Mexico's Lower House of Congress passed a bill on Friday to legalize the use of marijuana and cannabis for medical and scientific needs, a step closer to outright legalization in a country long scarred by warring drug cartels.
LATEST NEWS: With Obamacare in doubt, California asks insurers to double up on rate filings - NEW YORK (Reuters) - Health insurers seeking regulatory approval for 2018 individual insurance plans can file two sets of premium rates as a way to deal with market uncertainty created by Republicans' promise to repeal and replace Obamacare, a California state insurance regulator said on Friday.
LATEST NEWS: U.S. FDA approves Novartis' leukemia treatment - (Reuters) - The U.S. Food and Drug Administration approved Novartis AG's Rydapt as an initial treatment for acute myeloid leukemia (AML) as well as certain other blood disorders, the agency said on Friday.
LATEST NEWS: Home blood pressure monitors may not be accurate enough - (Reuters Health) – Even as doctors are increasingly relying on home blood pressure monitoring to manage patients with hypertension, many of the devices are too inaccurate to be useful, according to a small study.
LATEST NEWS: No vote on healthcare bill this week in U.S. House - WASHINGTON (Reuters) - U.S. House leaders have decided against holding a vote on a reworked healthcare system overhaul this week after failing to find the necessary support, congressional aides said on Thursday.